Literature DB >> 20881289

Effects of vitreous liquefaction on the intravitreal distribution of sodium fluorescein, fluorescein dextran, and fluorescent microparticles.

Lay Ean Tan1, Werhner Orilla, Patrick M Hughes, Susan Tsai, James A Burke, Clive G Wilson.   

Abstract

PURPOSE: The effects of vitreous liquefaction in the elderly on the distribution of drugs from intravitreal injections, depots, or devices remains unclear. The purpose of the present study was to develop a liquefied vitreous model that simulates the aged condition, to enable the study of clinically relevant drug distribution.
METHODS: Dutch-belted rabbits were used to develop a study model using hyaluronidase as a vitreolytic agent. The effects of experimental vitreous liquefaction were investigated on intravitreal sodium fluorescein, fluorescein isothiocyanate-dextran (MW 150 kDa), and a suspension of 1-μm fluorescent particles. The distribution of these model compounds was monitored by retinal angiography with a confocal laser scanning system and ocular fluorophotometer.
RESULTS: Hyaluronidase-treated vitreous humor (n = 6) was found to decrease the gel phase to 41% ± 9% (wt/wt; mean ± SD) compared with 81% ± 9% in the control eyes (n = 8; P < 0.05). The distribution of sodium fluorescein and fluorescein isothiocyanate dextran was greater in the liquefied vitreous than in the control. In comparison to the normal vitreous, fluorescent particles sedimented faster in the liquefied vitreous, and the distribution was more dispersed and scattered.
CONCLUSIONS: A model of vitreous liquefaction in rabbits was successfully generated using intravitreal hyaluronidase. Small and large fluorescent molecules as well as particulates were distributed faster in liquefied vitreous than in the control. The results suggest enhanced convective flow and subsequent faster clearance in liquefied vitreous.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20881289     DOI: 10.1167/iovs.10-5813

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  9 in total

1.  Extended Pharmacokinetic Model of the Rabbit Eye for Intravitreal and Intracameral Injections of Macromolecules: Quantitative Analysis of Anterior and Posterior Elimination Pathways.

Authors:  Marko Lamminsalo; Ella Taskinen; Timo Karvinen; Astrid Subrizi; Lasse Murtomäki; Arto Urtti; Veli-Pekka Ranta
Journal:  Pharm Res       Date:  2018-05-31       Impact factor: 4.200

2.  ISOPT Clinical Hot Topic Panel Discussion on Ocular Drug Delivery.

Authors:  Uday B Kompella; Abraham Domb; Arto Urtti; Ashwath Jayagopal; Clive G Wilson; Diane Tang-Liu
Journal:  J Ocul Pharmacol Ther       Date:  2019-06-28       Impact factor: 2.671

3.  Effect of vitreomacular adhesion on antivascular endothelial growth factor therapy for macular edema secondary to branch retinal vein occlusion.

Authors:  Ryo Terao; Kentaro Yuda; Kayo Kure; Tatsuya Inoue; Hiroshi Ohtsu; Yasuo Yanagi
Journal:  Jpn J Ophthalmol       Date:  2014-01-10       Impact factor: 2.447

4.  Ex vivo investigation of ocular tissue distribution following intravitreal administration of connexin43 mimetic peptide using the microdialysis technique and LC-MS/MS.

Authors:  Rohit Bisht; Abhirup Mandal; Ilva D Rupenthal; Ashim K Mitra
Journal:  Drug Deliv Transl Res       Date:  2016-12       Impact factor: 4.617

5.  Mesenchymal stem cell-derived extracellular vesicles and retinal ischemia-reperfusion.

Authors:  Biji Mathew; Sriram Ravindran; Xiaorong Liu; Leianne Torres; Mohansrinivas Chennakesavalu; Chun-Chieh Huang; Liang Feng; Ruth Zelka; Jasmine Lopez; Monica Sharma; Steven Roth
Journal:  Biomaterials       Date:  2019-01-09       Impact factor: 12.479

6.  Advanced glycation end-product accumulation reduces vitreous permeability.

Authors:  On-Tat Lee; Samuel D Good; Ricardo Lamy; Max Kudisch; Jay M Stewart
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-05       Impact factor: 4.799

Review 7.  In vitro dissolution testing models of ocular implants for posterior segment drug delivery.

Authors:  Muhammad Faris Adrianto; Febri Annuryanti; Clive G Wilson; Ravi Sheshala; Raghu Raj Singh Thakur
Journal:  Drug Deliv Transl Res       Date:  2021-08-11       Impact factor: 5.671

Review 8.  [Pharmacokinetics of intravitreally administered VEGF inhibitors].

Authors:  T U Krohne; F G Holz; C H Meyer
Journal:  Ophthalmologe       Date:  2014-02       Impact factor: 1.059

9.  sFlt Multivalent Conjugates Inhibit Angiogenesis and Improve Half-Life In Vivo.

Authors:  Eda I Altiok; Shane Browne; Emily Khuc; Elizabeth P Moran; Fangfang Qiu; Kelu Zhou; Jorge L Santiago-Ortiz; Jian-Xing Ma; Matilda F Chan; Kevin E Healy
Journal:  PLoS One       Date:  2016-06-03       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.